BI
APGN

Bulldog Investors’s Apexigen, Inc. Common Stock APGN Stock Holding History

Bulldog Investors’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-37,664
Closed -$374K – 273
2021
Q2 		$374K Hold
37,664
– – 0.1% 155
2021
Q1 		$370K Buy
+37,664
New +$377K 0.11% 142

Other funds holding APGN

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Bulldog Investors's APGN Position: Q3 2021 in Review

Bulldog Investors sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2021, closing a stake of 37,664 shares — an estimated $374K sold.

Bulldog Investors first reported a position in APGN in Q1 2021 and held it in 2 quarters. The position peaked at $374K in Q2 2021. 31 funds tracked by Wall St. Rank hold APGN as of Q3 2021.

  • Bulldog Investors reported no remaining Apexigen, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Bulldog Investors sold 37,664 Apexigen, Inc. Common Stock shares in Q3 2021, an estimated $374K.
  • Bulldog Investors first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Bulldog Investors's Apexigen, Inc. Common Stock position peaked at $374K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2021.

Based on Bulldog Investors's 13F filing for Q3 2021, filed 12 Nov 2021.